Replies to post #84813 on PharmaCyte Biotech Inc (PMCB)

[spiritthing]

IMO Hang on frosr6! Your about to see something you will wish you had been on the other side for.

[ambitious1]

May be so , but I don't think anyone in here had a gun put to their head to invest. We are doing at our own free will.That's why one has to do their due diligence and invest wisely.If we choose to invest our entire 401k .or mortgage money or children's college fees.Then we have ourselves to blame.

[DragonBear]

Pmcb is a scam...steady diet of nonsense PRs

The latest featuring Lohr. The scam angle being:

If we are again successful in shrinking the size of the tumors...This is an area where PharmaCyte can dramatically address an unmet medical need

Guess, Lohr being semi-retired missed the results of a recent trial:

Adding cisplatin to the standard gemcitabine/nab-paclitaxel drug treatment provided a very high rate of tumor shrinkage for patients

Linky

Then there is the Phase 1-2 study involving a CTGF Ab due to be completed in Dec 2018. Top line data presented in Jun showed 70% shrinkage. Lohr apparently missed the presentation at the Jun ASCO conference. This CT was started in 2014.

Yet this scam has ingrained the idea CIAB is the only hope to shrink PC tumors. Not only that but a Phase 1-2 trial will only have to run for 6 months to gain approval. So where's the IND that Kenny once definitively promised no later than the end of 2016? That he hinted would be ready by Q1 2018? Instead the SH is subjected to a blow by blow account of all the pre-clinical tests, which should've been completed "long ago". How long ago? Well, Austrianova was chirping back in 2005 it was close to running a CT.

Linky

Ya knows, the company formed to get CIAB to the market. The company that couldn't attract any private equity/Pharma financing to do so. Strange how no one was interested in the technology. Thus, 13 yrs later the PMCB drama of regular pre-clinical test PR pumps by Kenny et al in management.

Another too hilarious item in the Lohr PR pump of the idea an "immunological" effect could be obtained. Trying to make out Metronomic therapy with a alkylating agent has an immunological effect on PC? Better have that control arm of Metronomic Ifosfamide without CIAB included in the study Lohr. Else the FDA will never approve such claims. Meanwhile ARMO since gobbled up or acquired by Lilly did show an immunological effect with their drug.

Will CIAB ever file an IND? Time is money in the biotech/drug business. Or will Kenny start trotting out the diabetes, and MJ scam angles out to deflect SH attention away from the PC nonsense? How he plays the multiple scam angles is the only interesting thing about this scam.